Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001012975-14-000212
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-28 19:30:29
Reporting Period:
2014-03-27
Filing Date:
2014-03-28
Accepted Time:
2014-03-28 19:30:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR Pharmaceutical Preparations (2834) 244106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192212 O. Philippe Chambon C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1231092 James Niedel C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1247851 Ronald Hunt C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1340806 K Vijay Lathi C/o New Leaf Ventures
1200 Park Place, Suite 300
San Mateo CA 94043
No No Yes No
1441439 New Leaf Ventures Ii, L.p. C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
Yes No Yes No
1441563 Jeani Delagardelle C/o New Leaf Ventures
1200 Park Place, Suite 300
San Mateo CA 94043
No No Yes No
1441857 New Leaf Venture Management Ii, L.l.c. C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
Yes No Yes No
1441858 New Leaf Venture Associates Ii, L.p. C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
Yes No Yes No
1547100 Liam Ratcliffe C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-27 1,821,084 $0.00 1,821,084 No 4 C Direct
Common Stock Acquisiton 2014-03-27 733,880 $0.00 2,554,964 No 4 C Direct
Common Stock Acquisiton 2014-03-27 265,219 $0.00 2,820,183 No 4 C Direct
Common Stock Acquisiton 2014-03-27 117,342 $0.00 2,937,525 No 4 C Direct
Common Stock Acquisiton 2014-03-27 308,356 $0.00 3,245,881 No 4 C Direct
Common Stock Acquisiton 2014-03-27 66,049 $0.00 3,311,930 No 4 C Direct
Common Stock Acquisiton 2014-03-27 60,000 $21.02 3,371,930 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2014-03-27 20,942,466 $0.00 1,821,084 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-03-27 8,439,620 $0.00 733,880 $0.00
Common Stock Series D1 Convertible Preferred Stock Disposition 2014-03-27 3,050,019 $0.00 265,219 $0.00
Common Stock Series D2 Convertible Preferred Stock Disposition 2014-03-27 1,349,433 $0.00 117,342 $0.00
Common Stock Series E Convertible Preferred Stock Disposition 2014-03-27 3,546,094 $0.00 308,356 $0.00
Series B Convertible Preferred Stock Warrant Disposition 2014-03-27 759,565 $0.00 759,565 $0.45
Common Stock Series B Convertible Preferred Stock Disposition 2014-03-27 759,565 $0.00 66,049 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 X Direct
0 No 4 C Direct
Footnotes
  1. The shares automatically converted into Common Stock on a 1-for-11.5 basis upon the closing of the Issuer's initial public offering without payment of further consideration and had no expiration date.
  2. Represents shares directly beneficially owned by NLV II. New Leaf Venture Associates II, L.P. ("NLV Associates") is the general partner of NLV II and New Leaf Venture Management II, L.L.C. ("NLV Management") is the general partner of NLV Associates. Philippe O. Chambon, Jeani Delagardelle, Ronald Hunt, Vijay Lathi, James Niedel and Liam Ratcliffe are the individual managers of NLV Management (the "Individual Managers"). NLV Associates and NLV Management disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein. As one of six individual managers, each of the Individual Managers disclaims beneficial ownership over the shares reported herein, and in all events disclaims pecuniary interest except to the extent of his economic interest.
  3. Immediately exercisable. The warrant shall expire on the earlier of October 12, 2017 or the closing of the Issuer's initial public offering.